217 related articles for article (PubMed ID: 31163672)
1. Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia.
Darwish NHE; Sudha T; Godugu K; Bharali DJ; Elbaz O; El-Ghaffar HAA; Azmy E; Anber N; Mousa SA
Molecules; 2019 Jun; 24(11):. PubMed ID: 31163672
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.
Kim YR; Eom JI; Kim SJ; Jeung HK; Cheong JW; Kim JS; Min YH
J Pharmacol Exp Ther; 2010 Nov; 335(2):389-400. PubMed ID: 20699435
[TBL] [Abstract][Full Text] [Related]
3. A novel nanoformulation of parthenolide coated with polydopamine shows selective cytotoxicity and induces apoptosis in gastric cancer cells.
Karimian Ensaf P; Goodarzi MT; Homayouni Tabrizi M; Neamati A; Hosseinyzadeh SS
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4435-4445. PubMed ID: 38108837
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia.
Jenkins C; Hewamana S; Gilkes A; Neelakantan S; Crooks P; Mills K; Pepper C; Burnett A
Br J Haematol; 2008 Dec; 143(5):661-71. PubMed ID: 19036014
[TBL] [Abstract][Full Text] [Related]
5. Levan enhanced the NF-κB suppression activity of an oral nano PLGA-curcumin formulation in breast cancer treatment.
Eskandari Z; Bahadori F; Yenigun VB; Demiray M; Eroğlu MS; Kocyigit A; Oner ET
Int J Biol Macromol; 2021 Oct; 189():223-231. PubMed ID: 34419542
[TBL] [Abstract][Full Text] [Related]
6. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of FLT3 and NF-κB selective inhibitors on acute myeloid leukemia in vivo.
Wang C; Lu J; Wang Y; Bai S; Wang Y; Wang L; Sheng G
J Biochem Mol Toxicol; 2012 Jan; 26(1):35-43. PubMed ID: 21928377
[TBL] [Abstract][Full Text] [Related]
8. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.
Guzman ML; Rossi RM; Karnischky L; Li X; Peterson DR; Howard DS; Jordan CT
Blood; 2005 Jun; 105(11):4163-9. PubMed ID: 15687234
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin plays a unique role in resistance of CD34+/CD123+ human leukemia cell lines KG1a to parthenolide.
Mohammadi S; Zahedpanah M; Ghaffari SH; Shaiegan M; Nikbakht M; Nikugoftar M
Life Sci; 2017 Nov; 189():89-95. PubMed ID: 28935249
[TBL] [Abstract][Full Text] [Related]
10. An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination.
Pallarès V; Unzueta U; Falgàs A; Sánchez-García L; Serna N; Gallardo A; Morris GA; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
J Hematol Oncol; 2020 Apr; 13(1):36. PubMed ID: 32295630
[TBL] [Abstract][Full Text] [Related]
11. Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target.
Zhou J; Ching YQ; Chng WJ
Oncotarget; 2015 Mar; 6(8):5490-500. PubMed ID: 25823927
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-κB signaling pathway.
Wang Y; Tang P; Chen Y; Chen J; Ma R; Sun L
Biochem Biophys Res Commun; 2017 Jun; 488(1):60-66. PubMed ID: 28478034
[TBL] [Abstract][Full Text] [Related]
15. Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells.
Zhang H; Xu H; Zhang R; Zhao X; Liang M; Wei F
Cancer Chemother Pharmacol; 2020 Aug; 86(2):257-266. PubMed ID: 32696214
[TBL] [Abstract][Full Text] [Related]
16. The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells.
Dai Y; Guzman ML; Chen S; Wang L; Yeung SK; Pei XY; Dent P; Jordan CT; Grant S
Br J Haematol; 2010 Oct; 151(1):70-83. PubMed ID: 20701602
[TBL] [Abstract][Full Text] [Related]
17. Molecular target therapy of AKT and NF-kB signaling pathways and multidrug resistance by specific cell penetrating inhibitor peptides in HL-60 cells.
Davoudi Z; Akbarzadeh A; Rahmatiyamchi M; Movassaghpour AA; Alipour M; Nejati-Koshki K; Sadeghi Z; Dariushnejad H; Zarghami N
Asian Pac J Cancer Prev; 2014; 15(10):4353-8. PubMed ID: 24935396
[TBL] [Abstract][Full Text] [Related]
18. Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML).
Omsland M; Bruserud Ø; Gjertsen BT; Andresen V
Oncotarget; 2017 Jan; 8(5):7946-7963. PubMed ID: 27974700
[TBL] [Abstract][Full Text] [Related]
19. Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane.
Liang B; Jiang D; Pan L; Xiong F; Feng S; Wu S; Ye H; Yu Z; Shi C; Gao S
Acta Biomater; 2022 Jun; 145():246-259. PubMed ID: 35405327
[TBL] [Abstract][Full Text] [Related]
20. [Expression of NF-kappaB mRNA in acute myeloid leukemia].
Liu M; Wei XD; Lü XD; Fan RH; Yin QS; Zhou J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):359-62. PubMed ID: 20416168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
